Abstract
In recent years there has been renewed interest and focus on mitochondria of animal and human tissues. This interest commenced in the latter part of the past century and has gained momentum during the first eight years of this new millennium. The well accepted reason is that mitochondria are now recognized to represent not only “power houses“, i.e., the ATP production factories of tissues essential for cell life, but in response to a variety of different “cues” may participate significantly also in cell death, both that associated with normal turnover and that associated with disease. Conversely, in cancers (particularly the advanced) their mitochondria interact with hexokinase 2 (HK-2) resulting in suppression of cell death while supporting cell growth via enhanced glycolysis, even in the presence of oxygen (Warburg effect). The identification/elucidation of proteins and mechanisms involved in deciding and/or participating in cell fate (i.e., life, death, or cancer) has focused to a large extent on the mitochondrial outer compartment, which is taken here to collectively include the outer membrane, the space between the inner and outer membranes, and contact regions between these two membranes. Among the established proteins believed to be involved in events related to cell fate are “VDACs” that form the basis of this mini-review series. This brief introductory review focuses mainly on the past discovery by the author and colleagues that VDAC located within the outer mitochondrial compartment and its binding partner HK-2 are pivotal players in the “Warburg effect” in cancer. As one case in point, when glucose is added to liver cytosol (mitochondria-free) the rate of glycolysis is very low. However, upon addition of tumor mitochondria containing VDAC bound HK-2, the low glycolytic rate is increased to a high rate near that catalyzed by the tumor cytoplasm from which the tumor mitochondria were derived.
References
Al Jamal JA (2005) Protein J 24:1–8
Arora KK, Pedersen PL (1988) J Biol Chem 263:17422–17428
Baines CP, Kaiser RA, Sheiko T, Craigen WJ, Molkentin JD (2007) Nat Cell Biol 9:550–555
Bustamante E, Pedersen PL (1977) Proc Nat Acad Sci USA 74:3735–3739
Bustamante E, Pedersen PL (1980) Biochemistry 19:4972–4977
Bustamante E, Morris HP, Pedersen PL (1978) Adv Exp Biol Med 92:363–380
Bustamante E, Morris HP, Pedersen PL (1981) J Biol Chem 256:8699–8704
Chen C, Ko Y, Delannoy M, Ludtke SJ, Chiu W, Pedersen PL (2004) J Biol Chem 279:31761–31768
Chiara F, Castellaro D, Marin O, Petronilli V, Brusilow WS, Juhaszova M, Sollott SJ, Forte M, Bernardi P, Rasola A (2008) PLOS ONE 3:e1852
Colombini M (2007) Methods Cell Biol 12:835–840
DiChiro G, DeLaPaz RL, Brooks RA, Sokoloff L, Kornblith PL, Smith BH, Patronas NJ, Kufta CV, Kessler RM, Johnston GS, Manning RG, Wolf AP (1982) Neurology 32:1323–1329
Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N (2001) Genes Dev 15:1406–1418
Han D, Antures F, Canali R, Rettori D, Cadenas E (2003) J Biol Chem 278:5557–5563
Indo T, Wan CN, Casella V et al (1978) J Label Compds Radiopharm 24:174–183
Jiang X, Wang X (2004) Annu Rev Biochem 73:87–106
Jiang JY, Han CR, Jeong YJ, Kim HJ, Lim HS, Lee KH, Park HO, Oh WM, Kim SH Kim WJ (2007a) Neurosci Lett 411:222–227
Jing W, Du B, Chi Z, Ma L, Wang S, Zhang X, Wu W, Wang X, Xu G, Guo C (2007b) J Neurosci Res 85:3160–3170
Kikuchi T, Yoshida Y, Morioka T, Gejyo F, Oite T (2008) Mod Rheumatol June 21 (in press)
Ko YH, Delannoy M, Hullihen J, Chiu W, Pedersen PL (2003) J Biol Chem 278:12305–12309
Lemaster JJ, Holmuhamedov E (2006) Biochim Biophys Acta 1762:181–190
Marin R, Ramirez CM, Gonzalez M, Gonzalez-Munoz E, Zorzano A, Camps M, Alonzo R, Diaz M (2007) Mol Membr Biol 24:148–1460
Mathupala SP, Ko YH, Pedersen PL (2006) Oncogene 25:4777–4786
Nakashima RA, Mangan PS, Colombini M, Pedersen PL (1986) Biochemistry 25:1015–10121
Nakashima RA, Paggi MG, Scott LJ, Pedersen PL (1988) Can Res 48:913–919
Neuzil J, Wang X-F, Dong L-F, Low P, Ralph SJ (2006) FEBS Lett 580:5125–5129
Pastorino JG, Shulga N, Hoek JB (2002) J Biol Chem 277:7610–7618
Rose IA, Warms JV (1967) J Biol Chem 242:1635–1645
Sampson MJ, Lowell RS, Craigen WJ (1997) J Biol Chem 272:18966–18973
Shoshan-Barmatz V, Israelson A, Brdiczka D, Shew SS (2006) Curr Pharm Des 12:2249–2270
Warburg O (1930) The metabolism of tumours. London. Constable
Warburg O (1956) Science 124:269–270
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pedersen, P.L. Voltage dependent anion channels (VDACs): a brief introduction with a focus on the outer mitochondrial compartment’s roles together with hexokinase-2 in the “Warburg effect” in cancer. J Bioenerg Biomembr 40, 123–126 (2008). https://doi.org/10.1007/s10863-008-9165-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10863-008-9165-7